scholarly journals Elevated FUS/TLS expression is negatively associated with E‑cadherin expression and prognosis of patients with non‑small cell lung cancer

Author(s):  
Dian Xiong ◽  
Yong‑Bing Wu ◽  
Chun Jin ◽  
Ji‑Jun Li ◽  
Jie Gu ◽  
...  
2021 ◽  
Vol 14 (5) ◽  
pp. 445
Author(s):  
Min Jung Geum ◽  
Chungsoo Kim ◽  
Ji Eun Kang ◽  
Jae Hee Choi ◽  
Jae Song Kim ◽  
...  

Antibiotic-induced dysbiosis may affect the efficacy of immune checkpoint inhibitors. We investigated the impact of antibiotics on the clinical outcomes of nivolumab in patients with non-small cell lung cancer (NSCLC). Patients who received nivolumab for NSCLC between July 2015 and June 2018 and who were followed up until June 2020 were included in a retrospective cohort analysis. Of 140 eligible patients, 70 were on antibiotics. Overall survival (OS) was shorter in patients on antibiotics (ABX) compared to those not on antibiotics (NoABX) (p = 0.014). OS was negatively associated with piperacillin/tazobactam (PTZ) (HR = 3.31, 95% CI: 1.77–6.18), days of therapy (DOT) ≥ 2 weeks (HR = 2.56, 95% CI: 1.30–5.22) and DOT of PTZ. The defined daily dose (DDD) in PTZ (r = 0.27) and glycopeptides (r = 0.21) showed weak correlations with mortality. There was no difference in progression-free survival (PFS) between ABX and NoABX; however, PFS was negatively associated with the antibiotic class PTZ and DOT of PTZ. Therefore, the use of a broad-spectrum antibiotic, such as PTZ, the long-term use of antibiotics more than 2 weeks in total and the large amount of defined daily dose of specific antibiotics were associated with decreased survival in patients receiving nivolumab for NSCLC.


2009 ◽  
Vol 69 (6) ◽  
pp. 2461-2470 ◽  
Author(s):  
Dessislava A. Nikolova ◽  
Irfan A. Asangani ◽  
Laura D. Nelson ◽  
Dennis P.M. Hughes ◽  
Doris R. Siwak ◽  
...  

2013 ◽  
Vol 30 (3) ◽  
pp. 1423-1429 ◽  
Author(s):  
ARUM KIM ◽  
EUN YOUNG KIM ◽  
EUN NA CHO ◽  
HYUNG JUNG KIM ◽  
SE KYU KIM ◽  
...  

Oncogene ◽  
2010 ◽  
Vol 29 (19) ◽  
pp. 2760-2771 ◽  
Author(s):  
L Asnaghi ◽  
W C Vass ◽  
R Quadri ◽  
P M Day ◽  
X Qian ◽  
...  

Tumor Biology ◽  
2017 ◽  
Vol 39 (7) ◽  
pp. 101042831770144 ◽  
Author(s):  
Jiang Du ◽  
Xiupeng Zhang ◽  
Haijing Zhou ◽  
Yuan Miao ◽  
Yong Han ◽  
...  

1998 ◽  
Vol 157 (4) ◽  
pp. 1319-1323 ◽  
Author(s):  
MAARTEN A. SULZER ◽  
MATHIE P. G. LEERS ◽  
JAN A. van NOORD ◽  
EWALD C. M. BOLLEN ◽  
PAUL H. M. H. THEUNISSEN

Sign in / Sign up

Export Citation Format

Share Document